6 completed, 5 unknown, 2 recruiting, 1 active not recruiting. 7 Phase 2, 5 Not applicable, 3 Phase 1, 2 Phase 3.
Follow Cystitis, Hemorrhagic: new trials by email Literature Review of Cystitis, Hemorrhagic trials Research Report on Cystitis, Hemorrhagic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Safety and Efficacy of LB-DTK-BKV in Patients With BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation LB-DTK-BKV, Standard-of-care - Hemorrhagic Cystitis | Phase 1 / Phase 2 | Not yet recruiting | LucasBio | 42 | 2026-09-01 | 2026-07-24 |
| Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation Catheter-Free Intravesical Instillation with a special syringe adapter - Interstitial Cystitis, Recurrent Cystitis | Recruiting | Jahn Ferenc South Pest Teaching Hospital | 300 | 2024-10-01 | 2024-12-12 | |
| Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT Moxibustion, Symptomatic supportive treatment - Moxibustion, Hematopoietic Stem Cell Transplantation | Not applicable | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 60 | 2024-08-15 | 2024-07-24 |
| Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT Moxibustion, Symptomatic treatment - Moxibustion, Hematopoietic Stem Cell Transplantation | Not applicable | Completed | Yi Zhang | 303 | 2024-03-21 | 2026-08-24 |
| Influence of Timing PTCy in AlloSCT Cyclophosphamide - Cyclophosphamide Toxicity, Allogenic Haematopoetic Transplantation | Completed | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 180 | 2023-06-26 | 2025-03-24 | |
| The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) Immunonutrition - Bladder Cancer, Interstitial Cystitis | Phase 3 | Recruiting | Centre Hospitalier Universitaire Vaudois | 232 | 2023-04-10 | 2025-12-09 |
| Chlorophyllin Tablets for Urinary Bleeding Following Radiation Therapy for Cancers of Pelvic Organs Sodium Copper Chlorophyllin - Hemorrhagic Cystitis | Phase 2 | Unknown | Tata Memorial Centre | 24 | 2022-03-26 | 2022-04-27 |
| Hyperbaric Oxygen Therapy for Hemorrhagic Cystitis Post HSCT Hyperbaric oxygen therapy - Stem Cell Transplant Complications | Not applicable | Unknown | Shandong Provincial Hospital | 150 | 2021-09-01 | 2021-09-08 |
| Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC) Posoleucel (ALVR105), Placebo - BK Virus Infection, Hemorrhagic Cystitis | Phase 3 | Terminated | AlloVir | 97 | 2021-03-18 | 2024-05-14 |
| The Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis LP-10 - Hemorrhagic Cystitis | Phase 2 | Completed | Lipella Pharmaceuticals, Inc. | 13 | 2020-10-01 | 2023-12-11 |
| Tolerability and Efficacy of INSTYLAN in Subjects With Moderate to Severe Hemorrhagic Cystitis INSTYLAN (Sodium Hyaluronate 80mg/50ml) - Hemorrhagic Cystitis | Not applicable | Unknown | LIDDE Therapeutics | 30 | 2020-05-15 | 2021-01-06 |
| A Double Blind Randomized Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis Decidual stromal cells, Placebo - Hemorrhagic Cystitis, Stem Cell Transplantation | Phase 2 | Unknown | Karolinska Institutet | 20 | 2014-03-01 | 2014-06-25 |
| Intravesical Cidofovir for Hemorrhagic Cystitis Cidofovir, Probenecid - Blood And Marrow Transplantation | Phase 1 | Completed | M.D. Anderson Cancer Center | 6 | 2013-09-01 | 2016-12-06 |
| A Pilot Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis Decidual Stromal Cell therapy - Hemorrhagic Cystitis | Phase 1 / Phase 2 | Completed | Karolinska Institutet | 12 | 2011-11-01 | 2014-06-24 |
| Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis Cidofovir, No Cidofovir - Transplantation Infection | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 27 | 2011-03-17 | 2026-09-18 |
| Efficacy and Safety of Activated Recombinant Human Factor VII in Refractory Haemorrhagic Cystitis activated recombinant human factor VII - Other Haemostasis Disorder, Haemorrhagic Cystitis | Phase 2 | Completed | Novo Nordisk A/S | 7 | 2001-09-01 | 2017-01-12 |
| Cidofovir Instillation in Hematopoietic Stem Cell Transplant (HSCT) Recipients With Hemorrhagic Cystitis Cidofovir - Cystitis, Bladder Diseases | Not applicable | Withdrawn | M.D. Anderson Cancer Center | 2019-05-14 |
Cystitis (4) · Urinary Bladder Diseases (3) · Cystitis, Interstitial (2) · Urinary Bladder Neoplasms (2) · Virus Diseases (2) · Adenoviridae Infections (1) · Endometriosis (1) · Infections (1) · Malnutrition (1) · Pain (1) · Urinary Bladder, Neurogenic (1) · Urinary Tract Infections (1)
Female Urogenital Diseases (17) · Female Urogenital Diseases and Pregnancy Complications (17) · Male Urogenital Diseases (17) · Urogenital Diseases (17) · Urologic Diseases (17) · Urinary Bladder Diseases (14) · Cystitis (13) · Infections (2) · Neoplasms (2) · Neoplasms by Site (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Urogenital Neoplasms (2) · Urologic Neoplasms (2)
Cidofovir (3) · Moxibustion (2) · Cyclophosphamide (1) · Hyperbaric Oxygenation (1) · Immunonutrition Diet (1) · Probenecid (1) · Standard of Care (1) · chlorophyllin (1)
M.D. Anderson Cancer Center (3) · Karolinska Institutet (2) · AlloVir (1) · Centre Hospitalier Universitaire Vaudois (1) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · Jahn Ferenc South Pest Teaching Hospital (1) · LIDDE Therapeutics (1) · Lipella Pharmaceuticals, Inc. (1) · LucasBio (1) · Novo Nordisk A/S (1) · Shandong Provincial Hospital (1) · Tata Memorial Centre (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · Yi Zhang (1)
United States (5) · China (3) · Sweden (3) · France (2) · South Korea (2) · Spain (2) · Hungary (1) · India (1) · Italy (1) · Switzerland (1) · United Kingdom (1)
Roy F. Chemaly, MD, MPH, MBA (2) · Borje S. Andersson, MD,PHD (1) · Dr. Gagan Prakash (1) · Eun Sun Yoo, MD-PhD (1) · Ho-joon Im, MD-PhD (1) · Hoon Kook, MD-PhD (1) · Hyeon Jin Park, MD-PhD (1) · Hyoung Jin Kang, MD-PhD (1) · Jae-Cheol Jo, MD-PhD (1) · Joonho Moon, MD-PhD (1) · Peter Tenke, Professor of Urology (1) · Seung Min Hahn, MD-PhD (1)
PMID 17133240, PMID 26612873, PMID 38597860, PMID 39415282, PMID 40083556